Pfizer has sent data to the FDA, looking to get the green light on its COVID-19 vaccine for kids 5 to 11 soon.
Right now, the FDA is expected to analyze data for several weeks. This request comes as outbreaks in schools are growing higher and higher.
So far, only people 12 and older are eligible for the Pfizer shot.
